116 related articles for article (PubMed ID: 10638769)
1. Spot urine concentrations of type I collagen cross-linked N-telopeptides and deoxypyridinoline in psoriatic arthritis.
Al-Awadhi AM; Olusi SO; Al-Zaid NS; George S; Sugathan TN
Clin Rheumatol; 1999; 18(6):450-4. PubMed ID: 10638769
[TBL] [Abstract][Full Text] [Related]
2. Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis.
al-Awadhi AM; Olusi SO; al-Zaid NS; Prabha K; al-Jarallah KH; Ahmed AH; al-Salem I; Sedeqi H; Atteyah Y
Clin Exp Rheumatol; 1998; 16(5):569-72. PubMed ID: 9779304
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
4. Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis.
Iwamoto J; Takeda T; Ichimura S
Calcif Tissue Int; 2003 Apr; 72(4):491-7. PubMed ID: 12574873
[TBL] [Abstract][Full Text] [Related]
5. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients.
Alexandrakis MG; Passam FH; Malliaraki N; Katachanakis C; Kyriakou DS; Margioris AN
Clin Chim Acta; 2002 Nov; 325(1-2):51-7. PubMed ID: 12367766
[TBL] [Abstract][Full Text] [Related]
7. Comparison of analytical performance and biological variability of three bone resorption assays.
Ju HS; Leung S; Brown B; Stringer MA; Leigh S; Scherrer C; Shepard K; Jenkins D; Knudsen J; Cannon R
Clin Chem; 1997 Sep; 43(9):1570-6. PubMed ID: 9299935
[TBL] [Abstract][Full Text] [Related]
8. Serum osteocalcin levels in premenopausal rheumatoid arthritis patients.
Seriolo B; Ferretti V; Sulli A; Caratto E; Fasciolo D; Cutolo M
Ann N Y Acad Sci; 2002 Jun; 966():502-7. PubMed ID: 12114311
[TBL] [Abstract][Full Text] [Related]
9. Urinary markers of type I collagen degradation in the dog.
Allen MJ; Allen LC; Hoffmann WE; Richardson DC; Breur GJ
Res Vet Sci; 2000 Oct; 69(2):123-7. PubMed ID: 11020362
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.
Chung JH; Park MS; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Yonsei Med J; 2005 Jun; 46(3):388-93. PubMed ID: 15988811
[TBL] [Abstract][Full Text] [Related]
11. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
[TBL] [Abstract][Full Text] [Related]
12. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
[TBL] [Abstract][Full Text] [Related]
14. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Rosen HN; Dresner-Pollak R; Moses AC; Rosenblatt M; Zeind AJ; Clemens JD; Greenspan SL
Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749
[TBL] [Abstract][Full Text] [Related]
15. Correlations between biochemical markers of bone resorption and creatinine excretion.
Green JH
Scand J Clin Lab Invest; 2001 Feb; 61(1):27-32. PubMed ID: 11300608
[TBL] [Abstract][Full Text] [Related]
16. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
17. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
[TBL] [Abstract][Full Text] [Related]
18. The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.
Torikai E; Kageyama Y; Takahashi M; Suzuki M; Ichikawa T; Nagafusa T; Nagano A
Rheumatology (Oxford); 2006 Jun; 45(6):761-4. PubMed ID: 16436492
[TBL] [Abstract][Full Text] [Related]
19. Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.
Jakob C; Zavrski I; Heider U; Brux B; Eucker J; Langelotz C; Sinha P; Possinger K; Sezer O
Eur J Haematol; 2002 Jul; 69(1):37-42. PubMed ID: 12270060
[TBL] [Abstract][Full Text] [Related]
20. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
